Magtein Supplier India: Magtein® (Magnesium L-Threonate) is an ingredient attracting interest from nutraceutical brands exploring brain-health and sleep-focused formulations. A 2024 randomised, placebo-controlled clinical trial evaluated Magtein® in adults with self-reported sleep problems, examining sleep quality and daytime functioning. These findings create an opportunity for supplement brands to explore Magtein® in sleep and wind-down product concepts.
Magtein® is widely recognised in the nutraceutical market for its brain-health positioning. However, emerging research on sleep quality creates an opportunity for brands to consider new product concepts around evening routines, restorative sleep and next-day functioning.
For product developers, the opportunity is not simply to add another magnesium ingredient to an existing sleep formula. It is to understand the research, select an appropriate ingredient dose, choose a suitable delivery format and communicate the product’s intended benefits responsibly.
As a Magtein supplier in India, Avlaan Pharma works with brands and formulators exploring Magtein® for brain-health and sleep-focused product concepts. This guide covers the available sleep-study information, formulation considerations, potential ingredient combinations and what to expect from an ingredient supplier.
Key Takeaways
- A 2024 randomised, double-blind, placebo-controlled trial evaluated 1 g of Magtein® daily in 80 adults aged 35–55 with self-reported sleep problems.
- The study assessed objective sleep measures alongside subjective sleep and daytime-functioning measures.
- The supplied study summary reports improvements in deep sleep and REM sleep scores compared with placebo.
- The study used 1 g of Magtein® per day for 21 days. The supplied material states that this amount provides at least 72 mg of elemental magnesium.
- Formulators should distinguish between the amount of Magtein® and the amount of elemental magnesium.
- Product communication should focus on permitted sleep-quality or evening-routine claims rather than suggesting that a supplement treats insomnia.
Why a Magtein Supplier in India Is Looking Beyond Brain Health
Magnesium is commonly associated with relaxation and muscle function, which has made it a familiar ingredient in sleep and wellness products. However, evidence for individual magnesium forms and their effects on sleep should not be treated as interchangeable.
Magtein® is Magnesium L-Threonate, a specific magnesium ingredient studied in relation to brain health. Its research profile has attracted attention from brands interested in cognitive-health formulations.
A 2024 clinical trial also examined its potential relationship with sleep quality and daytime functioning. This creates a possible opportunity for brands that want to explore a sleep-focused product using a specifically studied magnesium ingredient.
Can Magtein® Be Used in Sleep Supplements?
Magtein® can be considered for sleep-focused formulation concepts, subject to ingredient specifications, permitted use, dosage requirements and applicable regulations.
The 2024 trial described in this article evaluated 1 g of Magtein® per day in adults with self-reported sleep problems over 21 days. The supplied study summary reports improvements in certain objective sleep measures and aspects of daytime functioning compared with placebo.
However, the study population had self-reported sleep problems, not necessarily diagnosed sleep disorders. The findings should not be presented as proof that Magtein® treats insomnia or other medical conditions.
For brands, the more appropriate product-development direction is to investigate sleep-quality and evening-routine positioning, with all final claims reviewed against the available evidence and applicable Indian regulations.
What the 2024 Magtein® Sleep Trial Measured
The supplied article identifies a 2024 randomised, double-blind, placebo-controlled trial published in Sleep Medicine: X.
The study details are summarised below.
| Study element | Details in the supplied research summary |
|---|---|
| Study design | Randomised, double-blind, placebo-controlled, parallel-arm |
| Participants | 80 adults aged 35–55 with self-reported sleep problems |
| Magtein® dose | 1 g per day |
| Duration | 21 days |
| Subjective measures | Insomnia Severity Index, Leeds Sleep Evaluation Questionnaire and Restorative Sleep Questionnaire |
| Objective measures | Nightly sleep and activity tracking using an Oura ring |
| Journal | Sleep Medicine: X |
| Publication year | 2024 |
What Did the Study Report?
According to the supplied study summary, the Magtein® group showed significant improvements compared with placebo in:
- Oura-measured deep sleep score.
- Oura-measured REM sleep score.
- Activity and readiness scores.
- Reported mood, energy and alertness.
- Reported daily productivity.
The study design is relevant when developing product communication. The participants had self-reported sleep problems, and the research examined sleep-related outcomes over a defined period.
Brands should therefore avoid extending the findings into claims about curing insomnia, treating sleep disorders or guaranteeing improved sleep for every consumer.
Additional Research on Cognitive Performance and Sleep
The supplied material also references a separate six-week randomised, placebo-controlled trial published in Frontiers in Nutrition in 2026.
According to the supplied summary, the trial involved 100 adults aged 18–45 and evaluated a daily 2 g dose in relation to cognitive performance and sleep quality.
This provides another research area for brands interested in the relationship between sleep and next-day cognitive performance. Before using either study in commercial materials, obtain the original publication and confirm the exact results, study limitations, ingredient identity and permitted use of the research findings.
Who Could Be the Target Audience for a Magtein® Sleep Product?
A sleep-focused supplement should have a clearly defined consumer group. The research population and the intended product audience can help guide the initial formulation brief.
Three potential segments are worth considering.
1. Mid-Career Professionals
These consumers may have long working days, extended screen time and demanding schedules. They may be interested in products that fit into a consistent evening wellness routine.
Potential format: Evening capsules or a powder sachet.
Communication direction: Supporting a consistent evening routine and sleep quality, where permitted.
2. Existing Magnesium Supplement Users
Some consumers already recognise magnesium as an ingredient in wellness and relaxation products. A formulation featuring Magtein® can provide a different ingredient proposition for brands looking to communicate its specific research background.
Potential format: Daily capsules, tablets or sachets.
Communication direction: Ingredient identity, research information and responsible product education.
3. Brain-Health and Cognitive-Wellness Consumers
Consumers interested in focus, mental performance and cognitive wellness may also be interested in products designed around evening routines.
A brand could explore separate day and night products rather than trying to make one formulation serve multiple purposes.
Potential format: A morning cognitive-health product and a separate evening formulation.
These are potential marketing segments, not established clinical indications. Product suitability, age restrictions and warnings should be determined through the appropriate regulatory and safety review.
Building a Day-and-Night Product Range | Magtein supplier India
Magtein® has been studied in brain-health and sleep-related research. This gives brands an opportunity to consider a coordinated product range, with separate formulations for different consumer routines.
| Formulation element | Morning SKU | Evening SKU |
|---|---|---|
| Core ingredient | Magtein® | Magtein® |
| Product direction | Focus and mental clarity | Sleep quality and evening routine |
| Potential supporting ingredients | Selected B vitamins | Glycine or suitable calming botanicals |
| Potential format | Capsule or tablet | Powder sachet or capsules |
| Main consideration | Daily convenience | Serving size, taste and evening use |
A day-and-night range should not be treated as a clinical recommendation. Each SKU needs its own formulation rationale, ingredient quantities, compatibility assessment and claims review.
Separate products can also make the consumer message clearer: one product is designed around a daytime routine, while the other is designed around an evening routine.
Magtein® Dosage: Understanding the Study Dose
The supplied research summary identifies 1 g of Magtein® per day as the dose used in the 2024 sleep trial. It also states that this quantity provides at least 72 mg of elemental magnesium.
This distinction is important during formulation development.
Magtein® ingredient quantity and elemental magnesium quantity are not the same measurement.
When preparing a product brief, brands should confirm the exact ingredient specification and recommended use conditions with the supplier. Do not calculate the finished-product serving solely from the elemental magnesium figure.
Choosing a Suitable Delivery Format
Capsules
A capsule format may suit consumers who already have a daily supplement routine. The formulator should assess the total ingredient quantity, capsule capacity and number of capsules required per serving.
Powder sachets
A sachet may be suitable for a larger ingredient serving or a warm-drink concept. Evaluate taste, solubility, dispersibility, moisture sensitivity and compatibility with other ingredients.
Tablets
Tablets can offer a convenient daily format. However, the development team should assess tablet weight, hardness, compression behaviour, disintegration and moisture uptake.
Combination products
If the formula includes additional active ingredients, check that the Magtein® quantity is appropriate for the product brief. Avoid reducing the ingredient amount simply to accommodate too many additional ingredients without reassessing the formulation objective and supporting evidence.
Designing a Wind-Down Formula Around Magtein®
A focused formulation is often easier to develop and communicate than a product containing too many unrelated ingredients.
Avlaan recommends beginning with a clearly defined product objective and evaluating Magtein® alongside a small number of complementary ingredients.
Potential formulation considerations include:
1. Magtein® as the Core Ingredient
Begin by reviewing the intended Magtein® serving, technical specifications and available research documentation.
The supplied 2024 study used 1 g per day. Formulators should confirm the appropriate ingredient use conditions with the supplier and their regulatory team.
2. Glycine
Glycine is commonly considered in bedtime powder concepts. Its suitability, quantity and compatibility should be assessed for the intended product category.
3. Traditional Botanicals
Selected botanicals may be evaluated for a relaxation-focused product concept. Confirm botanical identity, standardisation, safety information, permitted use levels and regulatory status before inclusion.
4. Format and Timing
An evening sachet or capsule may suit a wind-down product. The final directions for use should be based on the formulation, ingredient documentation and applicable requirements.
5. Ingredients to Review Carefully
Avoid adding caffeine-containing botanicals or stimulants without a clear formulation rationale. Check the complete ingredient combination for safety, compatibility and consistency with the intended product positioning.
Formulation principle: Build the product around a clear objective. Each additional active should have a defined purpose and an appropriate supporting rationale.
Sleep Quality Positioning: Responsible Claim Language
Sleep supplements can easily drift into medical or treatment-related claims. Brands should carefully review product names, labels, websites, advertisements, retailer descriptions and promotional material.
| Avoid unsupported or medical-style claims | Consider carefully qualified wording where permitted |
|---|---|
| Cures insomnia | Supports sleep quality |
| Treats sleep disorders | Formulated for an evening wellness routine |
| Knocks you out | Designed for a wind-down routine |
| Clinically proven sleeping pill | Contains Magtein®, studied in a 2024 sleep-quality trial |
| Guarantees deep sleep | Developed around an ingredient studied for sleep-related outcomes |
These alternative phrases are not automatic regulatory approvals. Their suitability depends on the finished product, applicable FSSAI regulations, supporting evidence and the context in which the claims are presented.
The study population had self-reported sleep problems. That does not establish that Magtein® treats diagnosed insomnia or other sleep disorders.
For B2B communication, brands may discuss relevant research accurately and provide appropriate references. Consumer-facing packaging and advertising should use only claims that have been reviewed and are permitted for the product.
What to Expect From a Magtein Supplier in India
Choosing a supplier involves more than checking whether an ingredient is available. Brands need reliable technical information, batch documentation and clear communication during product development.
Before selecting a Magtein® supplier, consider these requirements:
- Ingredient authenticity: Request documentation confirming the identity and source of the supplied Magtein® material.
- Batch documentation: Ask for a Certificate of Analysis (CoA) for the relevant batch.
- Technical specifications: Review the ingredient specification, handling requirements and storage guidance.
- Trademark and logo guidance: Confirm the conditions for using the Magtein® name and logo in packaging and marketing.
- Research references: Request the original clinical study citations and relevant technical material.
- Formulation guidance: Discuss dosage form, serving size, ingredient compatibility and product-development requirements.
- Claims review support: Ask for technical information that can help your internal regulatory team assess proposed claims.
Magnesium-containing ingredients may have specific handling and storage requirements. Always follow the supplied ingredient documentation and the recommendations provided for the material.
Frequently Asked Questions
1. What does a Magtein supplier in India provide for a sleep product?
A supplier should provide genuine ingredient documentation, relevant batch CoAs, technical specifications, storage and handling guidance, and information about available clinical research. Trademark and logo usage guidance may also be required when developing a branded ingredient product. Formulation support can help brands assess delivery formats and product requirements.
2. What dose of Magtein® was used in the 2024 sleep study?
The supplied study summary states that participants received 1 g of Magtein® per day for 21 days. It also states that this amount provides at least 72 mg of elemental magnesium. Confirm the original publication and current ingredient specification before using these figures in a commercial product brief.
3. Can I claim that Magtein® treats insomnia?
Do not make an insomnia-treatment claim based on the supplied study. The research involved adults with self-reported sleep problems and does not establish that Magtein® treats diagnosed sleep disorders. Product claims must be reviewed against applicable regulations and supporting evidence.
4. Can one Magtein® product support both focus and sleep?
Brands can explore a product range addressing different consumer routines. However, separate morning and evening products may provide clearer positioning than a single formulation making multiple claims. Each product requires its own formulation and regulatory review.
5. Which format suits a Magtein® sleep product best?
Powder sachets and capsules are possible formats to evaluate. A powder sachet may accommodate a larger ingredient serving, while capsules may suit consumers who prefer conventional supplements. Tablets are another possibility, but require testing for compression, hardness, disintegration and moisture uptake.
6. What documents should I request from a Magtein supplier?
Request the ingredient specification, relevant batch CoA, technical data, storage and handling guidance, and supporting information about the ingredient’s identity. If you plan to use clinical research in your marketing materials, request the original study references and confirm that your proposed use of the research is accurate.
7. Can Avlaan Pharma support brands developing Magtein® products?
Avlaan Pharma supplies Magtein® for brands and formulators exploring brain-health and sleep-focused product concepts. Contact Avlaan to discuss ingredient documentation, clinical study references, samples and formulation requirements.
Partner With Avlaan Pharma for Magtein® Ingredient Requirements
Sleep and wind-down products are an established area of interest for nutraceutical brands. Magtein® provides an ingredient-specific research angle for companies exploring products around brain health and sleep quality.
A successful product still depends on accurate ingredient selection, suitable serving formats, formulation testing, technical documentation and responsible claims.
Avlaan Pharma works with supplement brands and formulators looking for Magtein® in India. Contact the team to discuss your ingredient requirements and product-development brief.
Contact Avlaan Pharma
- Email: info@avlaanpharma.com
- Phone: +91 735 855 1962
- Website: Avlaan Pharma
Explore the ingredient page: Magtein® Supplier India